Maze Therapeutics, a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal,...
Alessandra Vignola has joined Worldwide Clinical Trials (Worldwide), a global full-service contract research organization (CRO), as President of the Cardiovascular & Metabolic Business Unit. Vignola brings...
Flagship Pioneering demonstrated further acceleration in its strategic partnership with Pfizer Inc, announcing two research programs with Flagship-founded Quotient Therapeutics. Under the collaboration, the...
Artificial intelligence (AI) can use data from low-dose CT scans of the lungs to improve risk prediction for death from lung cancer, cardiovascular disease...
